Interestingly, ASXL1-MT/BAP1 promotes monocyte differentiation, while it inhibits terminal differentiation to macrophage, which may account for the frequent (40–50%) detection of ASXL1 mutations in CMML patients. This evidence concerns the gene BAP1 and chronic myelomonocytic leukemia.